Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Rosiñol

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Best Practice & Research. Clinical Haematology|July 20, 2005
Renal, hematologic and infectious complications in multiple myelomaJoan Bladé, Laura Rosiñol
Current Opinion in Oncology|October 9, 2008
Advances in therapy of multiple myelomaJoan Bladé, Laura Rosiñol
Current Treatment Options in Oncology|April 18, 2006
Smoldering multiple myeloma and monoclonal gammopathy of undetermined significanceJoan Bladé, Laura Rosiñol
Hematology/Oncology Clinics of North America|November 13, 2007
Complications of multiple myelomaJoan Bladé, Laura Rosiñol
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Bortezomib: a valuable new antineoplastic strategy in multiple myelomaJoan Bladé, M Teresa Cibeira, Laura Rosiñol
Blood|January 15, 2015
How I treat relapsed myelomaJoan Bladé, Laura Rosiñol, Carlos Fernández de Larrea
Seminars in Oncology|April 30, 2003
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?Joan Bladé, Silvia Montoto, Laura Rosiñol, et al.
Expert Review of Hematology|January 8, 2014
Initial treatment of transplant-eligible patients in multiple myelomaLaura Rosiñol, Shaji Kumar, Phillipe Moreau, et al.
Archives of Internal Medicine|March 2, 2005
Bortezomib-induced severe hepatitis in multiple myeloma: a case reportLaura Rosiñol, Silvia Montoto, Maria Teresa Cibeira, et al.
Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Best Practice & Research. Clinical Haematology|July 20, 2005
Renal, hematologic and infectious complications in multiple myelomaJoan Bladé, Laura Rosiñol
Current Opinion in Oncology|October 9, 2008
Advances in therapy of multiple myelomaJoan Bladé, Laura Rosiñol
Current Treatment Options in Oncology|April 18, 2006
Smoldering multiple myeloma and monoclonal gammopathy of undetermined significanceJoan Bladé, Laura Rosiñol
Hematology/Oncology Clinics of North America|November 13, 2007
Complications of multiple myelomaJoan Bladé, Laura Rosiñol
Acta Oncologica (Stockholm, Sweden)|August 25, 2005
Bortezomib: a valuable new antineoplastic strategy in multiple myelomaJoan Bladé, M Teresa Cibeira, Laura Rosiñol
Blood|January 15, 2015
How I treat relapsed myelomaJoan Bladé, Laura Rosiñol, Carlos Fernández de Larrea
Seminars in Oncology|April 30, 2003
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?Joan Bladé, Silvia Montoto, Laura Rosiñol, et al.
Expert Review of Hematology|January 8, 2014
Initial treatment of transplant-eligible patients in multiple myelomaLaura Rosiñol, Shaji Kumar, Phillipe Moreau, et al.
Archives of Internal Medicine|March 2, 2005
Bortezomib-induced severe hepatitis in multiple myeloma: a case reportLaura Rosiñol, Silvia Montoto, Maria Teresa Cibeira, et al.
Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.
Pageof 23